2015 American Transplant Congress
Recurrent IgA Nephropathy in Kidney Transplant Recipients Receiving a Steroid Sparing Immunosuppression Protocol
Background: Steroid sparing immunosuppression is increasingly used in order to avoid the many well-known side effects of steroids. It has been argued that steroid use…2015 American Transplant Congress
What Can UNOS Data Tell Us About Patient Outcomes After Primary Renal Allograft Failure?
Evidence based approaches to patient care after Renal Allograft Failure do not exist, despite this being a high mortality period. Access to retransplantation is important…2015 American Transplant Congress
Consideration of the Futility of Transplant: 50% Mortality at 5 Years
Baylor University Medical Center, Dallas, TX.
Introduction: Transplant recipients are globally sicker at the time of liver transplantation (LT) in the current era. We sought to devise and validate a model…2015 American Transplant Congress
Repeat Donor HLA Mismatch Antigens and Kidney Transplant Outcome
Background: Historically, poorer outcome has been reported in kidney re-transplant patients with repeat HLA mismatch antigens. Transplant practice has evolved. Risk of repeat mismatch antigen…2015 American Transplant Congress
Elective Allograft Nephrectomy After Transplant Failure
University Hospitals, Transplant Institute, Cleveland, OH.
Background/Methods: Because of high rates of allograft intolerance and alloantibody sensitization after kidney transplant failure, we undertook a pilot study of elective allograft nephrectomy (ENx)…2015 American Transplant Congress
Portal Flow <1000 cc Is Not Associated With Early Graft Dysfunction in Orthotopic Liver Transplantation
Purpose: The aim of our study was to determine whether a portal flow <1000 cc after orthotopic liver transplantation (OLT) is associated with a higher…
- « Previous Page
- 1
- …
- 53
- 54
- 55